Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fibrotic Interstitial Lungs Diseases”

73 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 73 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT07141810
What this trial is testing

Efficacy and Safety of Early Antifibrotic Therapy for Non-progressive Fibrotic Interstitial Lung Disease

Who this might be right for
Fibrotic Interstitial Lung Disease
Shanghai Pulmonary Hospital, Shanghai, China 104
Post-approval studies (Phase 4)Active Not RecruitingNCT05626387
What this trial is testing

An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis

Who this might be right for
Hypersensitivity Pneumonitis
Post Graduate Institute of Medical Education and Research, Chandigarh 144
Not applicableLooking for participantsNCT07486206
What this trial is testing

Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial

Who this might be right for
Interstitial Lung Disease (ILD)Fibrotic Interstitial Lung DiseaseIdiopathic Pulmonary Fibrosis (IPF)+2 more
Hospital de Granollers 152
Not applicableActive Not RecruitingNCT04680832
What this trial is testing

Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILD

Who this might be right for
Pulmonary Fibrosis
Erasmus Medical Center 600
Not applicableUnknownNCT04019080
What this trial is testing

Real-Life Use of Anti-fibrotic Drugs in Patients With Idiopathic Pulmonary Fibrosis in Sweden

Who this might be right for
Idiopathic Pulmonary Fibrosis
Karolinska University Hospital 400
Not applicableEnrolling By InvitationNCT07512687
What this trial is testing

Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional Hypoxemia

Who this might be right for
Interstitial Lung DiseaseChronic Obstructive Pulmonary DiseaseHypoxemia
State University of New York at Buffalo 24
Not applicableStudy completedNCT07679854
What this trial is testing

Nasal High-flow Oxygen Therapy During Rehabilitive Exercise Training in ILD

Who this might be right for
Interstitial Lung Disease (ILD)
Frédéric Hérengt 60
Not applicableLooking for participantsNCT06476470
What this trial is testing

Taiwan Interstitial Lung Disease Multi-center Investigation and Registry

Who this might be right for
Interstitial Lung DiseaseComorbidities and Coexisting ConditionsPulmonary Arterial Hypertension+2 more
Taichung Veterans General Hospital 10,000
Early research (Phase 1)Active Not RecruitingNCT04262167
What this trial is testing

Human Autologous Lung Stem Cell Transplant for Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis and Progressive Fibrotic Interstitial Lung Disease
University of North Carolina, Chapel Hill 24
Post-approval studies (Phase 4)Study completedNCT04619680
What this trial is testing

The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19

Who this might be right for
Pulmonary FibrosisInterstitial Lung DiseaseRespiratory Disease
Icahn School of Medicine at Mount Sinai 103
Not applicableUnknownNCT05866198
What this trial is testing

Physical Activity and Quality of Life in Fibrotic Lung Diseases After Initiating Anti-fibrotic Therapy and Pulmonary Rehabilitation

Who this might be right for
Lung Diseases, Interstitial
University of South Florida 70
Post-approval studies (Phase 4)Looking for participantsNCT06479603
What this trial is testing

RCT of Nintedanib in Fibrotic Sarcoidosis

Who this might be right for
Sarcoidosis, Pulmonary
Post Graduate Institute of Medical Education and Research, Chandigarh 120
Not applicableUnknownNCT04409275
What this trial is testing

LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION

Who this might be right for
Pulmonary Fibrosis
Fundación para la Investigación del Hospital Clínico de Valencia 500
Not applicableStudy completedNCT05648734
What this trial is testing

Anti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19 Pulmonary Fibrosis

Who this might be right for
Post-COVID-19 SyndromeLung Fibrosis
Mansoura University 200
Not applicableLooking for participantsNCT06326957
What this trial is testing

Reducing Chronic Breathlessness in Adults by Following a Self-guided, Internet Based Supportive Intervention (SELF-BREATHE)

Who this might be right for
Chronic Obstructive Pulmonary DiseaseBronchiectasisInterstitial Lung Disease+5 more
King's College Hospital NHS Trust 246
Post-approval studies (Phase 4)UnknownNCT00637065
What this trial is testing

Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study

Who this might be right for
Pulmonary HypertensionInterstitial Lung DiseaseIdiopathic Pulmonary Fibrosis+1 more
Royal Brompton & Harefield NHS Foundation Trust 48
Not applicableStudy completedNCT03420235
What this trial is testing

Home Monitoring in Idiopathic Pulmonary Fibrosis; Improving Use of Anti-fibrotic Medication and Quality of Life

Who this might be right for
Idiopathic Pulmonary Fibrosis
Erasmus Medical Center 90
Not applicableLooking for participantsNCT04299945
What this trial is testing

Effects of Drinking Beetroot Juice on Exercise Performance in Patients With Fibrotic Interstitial Lung Disease

Who this might be right for
Interstitial Lung Disease
University of British Columbia 15
Large-scale testing (Phase 3)Ended earlyNCT03267108
What this trial is testing

Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension

Who this might be right for
Pulmonary FibrosisPulmonary Hypertension
Bellerophon Pulse Technologies 145
Not applicableLooking for participantsNCT07332117
What this trial is testing

A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic Medications

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)Progressive Pulmonary Fibrosis
Royal Brompton & Harefield NHS Foundation Trust 30
Next Page